![Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies - ACR Meeting Abstracts Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2020/09/OCMVWLVW-899622-1-ANY.jpg)
Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies - ACR Meeting Abstracts
![PDF) A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study PDF) A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study](https://i1.rgstatic.net/publication/258505154_A_comparison_of_vascular_inflammation_in_psoriasis_rheumatoid_arthritis_and_healthy_subjects_by_FDG-PETCT_a_pilot_study/links/5ba9a1a7a6fdccd3cb70b4d5/largepreview.png)
PDF) A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study
![IJMS | Free Full-Text | In Vitro Wound Healing Properties of Novel Acidic Treatment Regimen in Enhancing Metabolic Activity and Migration of Skin Cells IJMS | Free Full-Text | In Vitro Wound Healing Properties of Novel Acidic Treatment Regimen in Enhancing Metabolic Activity and Migration of Skin Cells](https://www.mdpi.com/ijms/ijms-23-07188/article_deploy/html/images/ijms-23-07188-g001.png)
IJMS | Free Full-Text | In Vitro Wound Healing Properties of Novel Acidic Treatment Regimen in Enhancing Metabolic Activity and Migration of Skin Cells
![Targeted Safety Analyses of Guselkumab (TREMFYA®): Long-term Results from Randomized Clinical Trials in Patients with Active Psoriatic Arthritis and Moderate to Severe Psoriasis - ACR Meeting Abstracts Targeted Safety Analyses of Guselkumab (TREMFYA®): Long-term Results from Randomized Clinical Trials in Patients with Active Psoriatic Arthritis and Moderate to Severe Psoriasis - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2021/09/ACR_1050676_1.jpg)
Targeted Safety Analyses of Guselkumab (TREMFYA®): Long-term Results from Randomized Clinical Trials in Patients with Active Psoriatic Arthritis and Moderate to Severe Psoriasis - ACR Meeting Abstracts
![Wilkes-Barre Times Leader, the Evening News, Wilkes-Barre Record from Wilkes-Barre, Pennsylvania on January Wilkes-Barre Times Leader, the Evening News, Wilkes-Barre Record from Wilkes-Barre, Pennsylvania on January](https://img.newspapers.com/img/thumbnail/396264416/400/400/0_0_4659_6868.jpg)
Wilkes-Barre Times Leader, the Evening News, Wilkes-Barre Record from Wilkes-Barre, Pennsylvania on January
Ta' psoriasis alvorligt - DAGENS BAGSIDE I EKSTRA BLADET Har du ikke læst dagens Ekstra Bladet, er hermed en opfordring fra kampagneredaktionen. EB bringer på bagsiden et interessant interview med Lars Iversen,
![PDF) Topical Tacrolimus Is Not Effective in Chronic Plaque Psoriasis: A Pilot Study | Attila Dobozy - Academia.edu PDF) Topical Tacrolimus Is Not Effective in Chronic Plaque Psoriasis: A Pilot Study | Attila Dobozy - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/53579528/mini_magick20190120-18058-1wpblh1.png?1548013453)